Literature DB >> 19357201

Real-time quantitative PCR to determine chlamydial load in men and women in a community setting.

R Wiggins1, S Graf, N Low, P J Horner.   

Abstract

We used a PCR method to quantify the loads of Chlamydia trachomatis organisms in self-collected urine and vulvovaginal swab (VVS) samples from 93 women and 30 men participating in the Chlamydia Screening Studies Project, a community-based study of individuals not seeking health care. For women, self-collected VVS had a higher mean chlamydial load (10,405 organisms/ml; 95% confidence interval [95% CI], 5,167 to 21,163 organisms/ml) than did first-void urines (FVU) (503 organisms/ml; 95% CI, 250 to 1,022 organisms/ml; P < 0.001). Chlamydial loads in female and male self-collected FVU specimens were similar (P = 0.634). The mean chlamydial load in FVU specimens decreased with increasing age in females and males. There was no strong statistical evidence of differences in chlamydial load in repeat male and female FVU specimens taken when patients attended for treatment a median of 23.5 (range, 14 to 62) and 28 (range, 13 to 132) days later, respectively, or in VVS taken a median of 35 (range, 14 to 217) days later. In this study, chlamydial load values for infected persons in the community who were not seeking treatment were lower than those published in other studies involving symptomatic patients attending clinical settings. This might have implications for estimates of the infectiousness of chlamydia. The results of this study provide a scientific rationale for preferring VVS to FVU specimens from women.

Entities:  

Mesh:

Year:  2009        PMID: 19357201      PMCID: PMC2691069          DOI: 10.1128/JCM.00005-09

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  8 in total

1.  Vulvovaginal-swab or first-catch urine specimen to detect Chlamydia trachomatis in women in a community setting?

Authors:  Sue Skidmore; Paddy Horner; Alan Herring; Joanne Sell; Ian Paul; Jane Thomas; E Owen Caul; Matthias Egger; Anne McCarthy; Emma Sanford; Chris Salisbury; John Macleod; Jonathan A C Sterne; Nicola Low
Journal:  J Clin Microbiol       Date:  2006-10-25       Impact factor: 5.948

2.  Chlamydia trachomatis load at matched anatomic sites: implications for screening strategies.

Authors:  Claude-Edouard C Michel; Christopher Sonnex; Christopher A Carne; John A White; Jose Paolo V Magbanua; Elpidio Cesar B Nadala; Helen H Lee
Journal:  J Clin Microbiol       Date:  2007-03-21       Impact factor: 5.948

3.  Quantitative Chlamydia trachomatis cultures: correlation of chlamydial inclusion-forming units with serovar, age, sex, and race.

Authors:  L O Eckert; R J Suchland; S E Hawes; W E Stamm
Journal:  J Infect Dis       Date:  2000-07-21       Impact factor: 5.226

4.  Quantitative culture of Chlamydia trachomatis: relationship of inclusion-forming units produced in culture to clinical manifestations and acute inflammation in urogenital disease.

Authors:  W M Geisler; R J Suchland; W L Whittington; W E Stamm
Journal:  J Infect Dis       Date:  2001-09-28       Impact factor: 5.226

Review 5.  Epidemiological, social, diagnostic and economic evaluation of population screening for genital chlamydial infection.

Authors:  N Low; A McCarthy; J Macleod; C Salisbury; R Campbell; T E Roberts; P Horner; S Skidmore; J A C Sterne; E Sanford; F Ibrahim; A Holloway; R Patel; P M Barton; S M Robinson; N Mills; A Graham; A Herring; E O Caul; G Davey Smith; F D R Hobbs; J D C Ross; M Egger
Journal:  Health Technol Assess       Date:  2007-03       Impact factor: 4.014

6.  Enhanced enzyme immunoassay with negative-gray-zone testing compared to a single nucleic Acid amplification technique for community-based chlamydial screening of men.

Authors:  Paddy Horner; Sue Skidmore; Alan Herring; Jo Sell; Ian Paul; Owen Caul; Matthias Egger; Anne McCarthy; Emma Sanford; Chris Salisbury; John Macleod; Jonathan Sterne; Nicola Low
Journal:  J Clin Microbiol       Date:  2005-05       Impact factor: 5.948

7.  The natural history of untreated Chlamydia trachomatis infection in the interval between screening and returning for treatment.

Authors:  William M Geisler; Chengbin Wang; Sandra G Morrison; Carolyn M Black; Claudiu I Bandea; Edward W Hook
Journal:  Sex Transm Dis       Date:  2008-02       Impact factor: 2.830

8.  Concordance of chlamydia trachomatis infections within sexual partnerships.

Authors:  S M Rogers; W C Miller; C F Turner; J Ellen; J Zenilman; R Rothman; M A Villarroel; A Al-Tayyib; P Leone; C Gaydos; L Ganapathi; M Hobbs; D Kanouse
Journal:  Sex Transm Infect       Date:  2007-10-02       Impact factor: 3.519

  8 in total
  12 in total

1.  Microbiological Characteristics of Chlamydia trachomatis and Neisseria gonorrhoeae Infections in South African Women.

Authors:  Jan Henk Dubbink; Dewi J de Waaij; Myrte Bos; Lisette van der Eem; Cécile Bébéar; Nontembeko Mbambazela; Sander Ouburg; Remco P H Peters; Servaas A Morré
Journal:  J Clin Microbiol       Date:  2015-10-28       Impact factor: 5.948

2.  Effect of HIV and chlamydia infection on rectal inflammation and cytokine concentrations in men who have sex with men.

Authors:  Marlies Heiligenberg; René Lutter; Dasja Pajkrt; Karin Adams; Henry De Vries; Titia Heijman; Maarten F Schim van der Loeff; Suzanne Geerlings
Journal:  Clin Vaccine Immunol       Date:  2013-07-31

3.  Impact of Chlamydia trachomatis in the reproductive setting: British Fertility Society Guidelines for practice.

Authors:  Valentine Akande; Cathy Turner; Paddy Horner; Andrew Horne; Allan Pacey
Journal:  Hum Fertil (Camb)       Date:  2010-09       Impact factor: 2.767

4.  Chlamydia trachomatis load in population-based screening and STI-clinics: implications for screening policy.

Authors:  Jeanne A M C Dirks; Petra F G Wolffs; Nicole H T M Dukers-Muijrers; Antoinette A T P Brink; Arjen G C L Speksnijder; Christian J P A Hoebe
Journal:  PLoS One       Date:  2015-03-31       Impact factor: 3.240

5.  Leucocyte esterase dip-stick test as a point-of-care diagnostic for urogenital chlamydia in male patients: A multi-center evaluation in two STI outpatient clinics in Paramaribo and Amsterdam.

Authors:  Menne Bartelsman; Henry J C de Vries; Maarten F Schim van der Loeff; Leslie O A Sabajo; Jannie J van der Helm
Journal:  BMC Infect Dis       Date:  2016-11-03       Impact factor: 3.090

6.  Spatial clustering of high load ocular Chlamydia trachomatis infection in trachoma: a cross-sectional population-based study.

Authors:  Anna Last; Sarah Burr; Neal Alexander; Emma Harding-Esch; Chrissy H Roberts; Meno Nabicassa; Eunice Teixeira da Silva Cassama; David Mabey; Martin Holland; Robin Bailey
Journal:  Pathog Dis       Date:  2017-07-31       Impact factor: 3.166

7.  Risk of pelvic inflammatory disease following Chlamydia trachomatis infection: analysis of prospective studies with a multistate model.

Authors:  Malcolm J Price; A E Ades; Daniela De Angelis; Nicky J Welton; John Macleod; Kate Soldan; Ian Simms; Katy Turner; Paddy J Horner
Journal:  Am J Epidemiol       Date:  2013-06-27       Impact factor: 4.897

8.  Chlamydia detection during the menstrual cycle: a cross-sectional study of women attending a sexual health service.

Authors:  Dana S Forcey; Jane S Hocking; Sepehr N Tabrizi; Catriona S Bradshaw; Marcus Y Chen; Glenda Fehler; Jessica L Nash; Christopher K Fairley
Journal:  PLoS One       Date:  2014-01-27       Impact factor: 3.240

9.  Chlamydia trachomatis genotypes in a cross-sectional study of urogenital samples from remote Northern and Central Australia.

Authors:  Philip M Giffard; Nicole C Brenner; Sepehr N Tabrizi; Suzanne M Garland; Deborah C Holt; Patiyan Andersson; Rachael A Lilliebridge; Steven Y C Tong; Mahdad Karimi; Prudence Boylan; Nathan Ryder; Tracy Johns; Gurmeet Singh
Journal:  BMJ Open       Date:  2016-01-06       Impact factor: 2.692

10.  Mobile nucleic acid amplification testing (mobiNAAT) for Chlamydia trachomatis screening in hospital emergency department settings.

Authors:  D J Shin; P Athamanolap; L Chen; J Hardick; M Lewis; Y H Hsieh; R E Rothman; C A Gaydos; T H Wang
Journal:  Sci Rep       Date:  2017-07-03       Impact factor: 4.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.